To: OriGen Customers and Partners OriGen Biomedical is open and maintaining current operations. We have been able to maintain full operating shifts and normal operating procedures. OriGen manufactures our products in Austin, TX and our facility is not affected. In response to the COVID-19 outbreak and to ensure continuous operations, we have activated our Incident Management System. OriGen’s Management Team is focused on actively monitoring our response to this unprecedented situation. At this time, OriGen’s manufacturing has not been affected by COVID-19. In order to minimize any potential impact on our organization, OriGen is implementing a number of additional measures to bolster our manufacturing operations and maintain the safety of our employees. Examples of these measures are listed below, but the list is not exhaustive.
- We have established an executive emergency response committee to immediately respond to the information provided by the Centers for Disease Control and Prevention (CDC) and local advisories.
- We are actively monitoring our supply chain for any disturbances or delays and proactively reaching out to suppliers who may be affected. At the time of this memo, OriGen’s supply chain is not affected by the COVID-19 outbreak.
- Internally, we are reinforcing healthy workplace practices including reiterating personal hygiene techniques, canceling large in-person meetings, restricting all business travel, increasing the use of teleworking for staff, encouraging social distancing, providing access to additional cleaning supplies and encouraging their use, and continuing to require sick employees to stay home.
- We have restricted facility visitors to business-critical visitors only, restricted any necessary visitor’s movement within the facility, and we are screening all visitors prior to their arrival at OriGen’s facilities.